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1016 The Journal of Thoracic and CardObjective: This study was undertaken to determine whether the presence of vortices
immediately above a prosthetic aortic valve could negatively influence the in vitro
hydrodynamic performances of a biologic or mechanical valve implanted in a new
Dacron polyester fabric conduit that incorporates sculpted sinuses of Valsalva.
Methods: With a computer-controlled pulse duplicator, the in vitro performance
(pressure differences, closure and leakage volumes, and energy losses) of a 25-mm
mechanical or biologic prosthesis implanted in a standard Dacron straight conduit or
in the new Dacron graft with a sculpted sinus were analyzed and compared.
Results: The mechanical and biologic prostheses at 7 L/min cardiac output showed
pressure drops across the valve of 8.72 mm Hg and 13.45 mm Hg, respectively,
when inserted in the new Valsalva-style graft and of 7.97 mm Hg and 12.94 mm Hg,
respectively, when inserted in the standard graft. The closure and leakage volumes
for mechanical valves were higher than those for biologic valves; however, the
presence or absence of sinuses did not result in significant differences in closure and
leakage volumes. The maximal total energy losses were 5.89% and 9.49% for
mechanical and biologic valves, respectively. No differences were evident between
the two different Dacron grafts for each prosthetic heart valve.
Conclusion: The normal opening and closing behavior of a prosthetic aortic valve
was not altered or modified by a different root shape above the heart valve. The
presence of vortices inside the pseudosinuses of Valsalva did not influence the
hydrodynamic properties of the biologic and mechanical valves tested.
T he evaluation of the hydrodynamic properties of prosthetic valves is a usefulindicator of expected clinical performance. Numerous devices and mockcirculations have been described for the measurement of in vitro perfor-
mances of artificial heart valves.1-3 The computer-controlled pulse duplicator is a
hydraulic model of the left human circulatory system and a well-established means
of obtaining information on the in vitro performance of prosthetic heart valves.1,4
However, the opening and closing characteristic of a biologic or mechanical valve
could potentially be modified by the presence or absence of vortices inside the aortic
root immediately above the implanted valve.
We have recently introduced into clinical practice a new Dacron polyester fabric
conduit (Gelweave Valsalva; Vascutek Terumo, Renfrewshire, United Kingdom)
that incorporates sculpted sinuses of Valsalva and has been found particularly
advantageous in both types of aortic valve–sparing operation, where it contributes
to a more anatomically and physiologically accurate reconstruction of the aortic
root.5,6 It has also been used in association with mechanical or biologic valves in a
composite aortic root replacement type of aortic root reconstruction because of its
improved adaptability to the patient’s anatomy.7,8 In fact, its peculiar shape is
characterized by a lower section that stretches horizontally and tends to reproduce
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sinuses. In this way it reduces the tension on the coronary
anastomoses once the aorta is under pressure and the heart
resumes beating. Unlike in the aortic valve–sparing opera-
tion, in which the use of the new Dacron graft allows the
reconstruction of three independent sinuses of Valsalva,
when used as a composite aortic root replacement its final
shape is that of a single, large, egg-shaped sinus to which
the two coronary ostia are attached.
The aim of this study was to determine whether the pres-
ence of vortices inside this single sinus immediately above the
prosthetic aortic valve could negatively influence the hydrody-
namic in vitro performances of a prosthetic heart valve. We
therefore analyzed and compared the in vitro performances of
mechanical and biologic aortic valve prostheses inside a con-
ventional straight Dacron conduit and inside the new Dacron
graft that incorporates the sinuses of Valsalva.
Materials and Methods
The design of the pulse duplicator, shown in Figure 1, is based on the
theoretic and experimental studies of Reul and colleagues. 4 This
device has been used in testing of several aortic prosthetic valves.9 To
obtain physical similarity to the in situ flow process, the physiologic
input and output impedances of the left human circulatory system are
simulated by means of tuned hydraulic elements, such as adjustable
compliances (Figure 1, 13 and 15) and resistances (Figure 1, 14 and
16). The flexible silicone ventricular model (Figure 1, 9) and the aortic
valved conduit (Figure 1, 10) are based on physiologic geometric
data.10 The volume displacement of the simulated left ventricle is
generated by an electrohydraulic drive unit (Figure 1, 17). The piston
expands and contracts the flexible model ventricle by means of the
fluid inside the compression chamber (Figure 1, 7) according to a
programmed volume-time function. An additional air volume serves
as a variable ventricular compliance. The computer-generated and
-controlled volume displacement signal facilitates a reliable and re-
producible simulation of the natural ventricular dynamics. By means
of frequency and piston amplitude variations, different circulatory
conditions are adjustable.
Two types of aortic valve prostheses of the same diameter of 25
mm, the St Jude mechanical prosthesis (St Jude Medical Inc,
Minneapolis, Minn) and the Hancock II bioprosthesis (Medtronic,
Inc, Minneapolis, Minn), were implanted in a standard 28-mm
Dacron conduit (Vascutek Terumo, Renfrewshire, United King-
dom) or in a new 28-mm Valsalva-style Dacron graft and then
inserted into the aortic position of the model. The design and
characteristics of the modified Dacron graft have been described in
detail elsewhere.7 In brief, it is composed of three portions: a
standard Dacron graft, a short portion of the same Dacron graft
with corrugation set perpendicularly (longitudinally) to the rest of
the graft (called the skirt, with a length equal to the diameter of the
graft), and a collar consisting of another short tract of a standard
Dacron tube of the same diameter attached at the end of the skirt.
The collar is needed to attach a valve prosthesis when performing
a composite aortic root replacement. Under the pressure of blood,
the tissue in the skirted portion of the graft will stretch horizontally
to mimic the bulged portion of the natural aortic root.
The Journal of ThoracicFor determination of pressure, volume, and energy losses,
pressure and flow signals are measured at several positions within
the pulse duplicator. Pressures are recorded within the atrium
(Figure 1, 2), in the apex region of the ventricle (Figure 1, 8), and
in the ascending aorta (Figure 1, 12) with strain gauge pressure
transducers (Cobe Laboratories, Inc, Lakewood, Colo). Flow is
recorded by electromagnetic flowmeters (Zedepa Instruments, Se-
Figure 1. Schematic drawing of pulse duplicator used in exper-
iment: reservoir (1), pressure transducers (2, 8, 12), atrium (3),
atrium chamber (4), flowmeters (5,11), mitral valve (6), compres-
sion chamber with fluid and air compliance (7), silicone ventricle
(9), aortic valve conduit (10), adjustable compliances (13, 15),
resistance (14), adjustable resistance (16), electrohydraulic drive
unit (17).attle, Wash). The mitral flowmeter (Figure 1, 5) is located up-
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(Figure 1, 10), the flowmeter (Figure 1, 11) is located 4 diameters
downstream. The sensor signals are processed by amplifiers and
special data-acquisition software. Each signal was averaged over
64 consecutive beats, and the averaged signals were then trans-
ferred to a second computer for off-line analysis. Therefore all
reported values are mean values for 64 cycles. Mean systolic
pressure difference, regurgitation volume, and energy losses were
determined according to the Food and Drug Administration Re-
placement Heart Valve Guidance.11
Mean Systolic Pressure Difference
The mean systolic pressure difference PSYS is the time integral of
ventricular pressure (PV) minus aortic pressure (PAo) during the
systolic period divided by systolic duration time (TSYS):
PSYS
1
TSYS

TSYS
(PV PA)dt
Closure and Leakage Volume
The closure volume (VCL) and leakage volume (VL) equations
represent the time integrals of aortic flow (V˙ ) during closure and
leakage periods, respectively.
VCL  V˙ dt
Figure 2. Mean systolic pressure differences at COs of
Food and Drug Administration conditions) for 25-mm
prostheses.TCL
1018 The Journal of Thoracic and Cardiovascular Surgery ● OctVL 
TL
V˙ dt
The closure volume is defined as that part of the regurgitant
volume that flows back through the valve during the time interval
of valve closing (TCL), in the time needed to move the occluder
from the open to the closed position. The leakage volume is
defined as that part of the regurgitant volume that passes during the
rest of the cycle (TL) and the closed state of the valve through the
gap between the occluder and the valve ring.
Energy Losses
Energy loss (E) is derived as the time integral of the product of
mean pressure difference and aortic flow during defined time
intervals, such as the systolic period (systolic energy loss), closure
interval (closure energy loss), and leakage interval (leakage energy
loss):
E 
T
P V˙ dt
All parameters were determined for four different cardiac out-
puts (COs): 2.0, 4.0, 5.0, and 7 L/min at a fixed beat rate of 70
beats/min, resulting in stroke volumes of 28, 57, 71, and 100 mL
respectively. The systolic duration was 35% of the cycle period.
The mean atrial and aortic pressures were kept constant at 10 mm
5, and 7 L/min (averaged over 64 consecutive beats per
Jude Medical (SJM) and 25-mm Hancock II valve2, 4,
StHg and 100 mm Hg, respectively, for all COs.
ober 2005
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Pressure Differences
The mean systolic pressure differences across the prosthetic
heart valves at each CO are shown in Figure 2. The pressure
drop across the valves increased with increasing flow rate.
The mechanical valves generally had lower pressure differ-
ences (related to the smaller effective orifice opening area of
the porcine valve). The bileaflet St Jude Medical valve
showed similar pressure differences at the various COs
when inserted in a Valsalva-type graft and in a standard
straight graft, with peaks at a CO of 7 L/min of 8.72 mm Hg
and 7.97 mm Hg, respectively. Similarly, the Hancock II
bioprosthesis did not show any significant differences when
inserted in a Valsalva-type graft or in a standard straight
graft, with a peak values at a CO of 7 L/min of 13.45 mm
Hg and 12.94 mm Hg, respectively.
Regurgitation (Closure and Leakage Volumes)
Figure 3 shows both closure and leakage volumes that have
been normalized to the respective stroke volumes at the
aforementioned COs and a constant heart rate of 70 beats/
min. In Table 1, these values are expressed as percentage of
stroke volume.
As expected, the closure and leakage volumes for me-
chanical valves were higher than those for biologic valves.
Figure 3. Closure and leakage volumes at COs of 2, 4, 5
and Drug Administration conditions) for 25-mm St JudThe presence or absence of sinuses did not result in signif-
The Journal of Thoracicicant differences in the closure and leakage volumes in
either the mechanical or the biologic prosthetic heart valve.
The lowest closure volume of the 25-mm St Jude Medical
prosthetic valve was 2.4 mL/beat in the standard straight
graft at a CO of 4 L/min, whereas the lowest closure volume
for the Hancock valve was 0.2 mL/beat in the Valsalva-type
7 L/min (averaged over 64 consecutive beats per Food
dical (SJM) and 25-mm Hancock II valve prostheses.
TABLE 1. Closure and leakage volumes expressed as per-
centage of stroke volume for the 25-mm St Jude Medical
and 25-mm Hancock II valve prostheses
Graft with sinuses
(% SV)
Straight graft
(% SV)
CO (L/min) Closure Leakage Closure Leakage
St Jude Medical
2 10.35 5.07 10.25 2.86
4 5.46 2.82 4.2 4.13
5 3.95 0.45 2.88 4.69
7 2.54 0.28 3.15 3.21
Hancock II
2 0.7 0 1.28 2.79
4 0.88 0.64 0.8 0.5
5 0.61 0 0.74 0
7 0.33 0 0.25 0, and
e MeSV, Stroke volume.
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volume of the St Jude Medical valve was 0.32 mL/beat at a
CO of 5 L/min in the Valsalva-type graft, whereas it was 0
mL/beat for the Hancock valve in both grafts at various
COs.
Energy Loss
Figure 4 depicts the accumulated transvalvular energy
losses for the systolic phase, the closing phase, and the
leakage phase for the mechanical and biologic valves. The
maximal total energy losses were 5.89% and 9.49% for
mechanical and biologic valves, respectively. No differ-
ences were evident between the two different Dacron grafts
for each prosthetic heart valve.
Discussion
Major problems associated with tissue and mechanical aor-
tic valve replacements include thrombosis, hemolysis, tissue
overgrowth, infection, calcification, valve wear, and exces-
sive pressure gradients. Despite these potential complica-
tions, the prognosis for patients receiving an aortic pros-
thetic heart valve remains good, with excellent long-term
survival and a good quality of life.
The simultaneous replacement of the aortic valve and the
entire ascending aorta with coronary reimplantation (com-
Figure 4. Accumulated energy losses (systolic, closure
64 consecutive beats per Food and Drug Administratio
Hancock II valve prostheses.posite aortic root replacement)12 has become a standard
1020 The Journal of Thoracic and Cardiovascular Surgery ● Octoperation for all cases of aortic valve disease associated
with aneurysm or dissection of the aortic root and ascending
aorta. Many modifications of the standard surgical tech-
nique have been described through the years. The popularity
and the increased need for this type of operation have
stimulated the development of composite valved conduits to
facilitate and expedite the surgical procedure. The use of
composite grafts has shown excellent long-term results with
an extremely low rate of complications.13,14
In recent years, we introduced into clinical practice an
originally designed Dacron conduit with the aim of obtain-
ing a more anatomically accurate reconstruction of the
aortic root.7 In particular, this newly designed conduit tends
to reproduce the bulged section of the aortic root corre-
sponding to the sinuses of Valsalva. The importance of the
sinuses of Valsalva in regulating the aortic valve motion
during the cardiac cycle has been extensively studied in
recent years.15 By using this Valsalva-type Dacron conduit,
it was possible to obtain more physiologically accurate
valve motion characteristics after either the remodeling or
the reimplantation type of valve-sparing procedure.5,6 Be-
cause of its peculiar shape, this modified Dacron graft has
also been used in composite aortic root replacement, where
it might facilitate the surgical technique and at the same
leakage) at COs of 2, 4, 5, and 7 L/min (averaged over
ditions) for 25-mm St Jude Medical (SJM) and 25-mm, and
n contime decrease the tension on coronary ostia anastomoses. As
ober 2005
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evident in those cases where the coronary ostia are more
difficult to mobilize (eg, reoperative cases, calcification, and
infection). In the case of composite aortic root replacement,
this new vascular prosthesis does not reproduce three inde-
pendent sinuses but rather a single, large, egg-shaped prox-
imal portion. Although vortices are present within this sin-
gle egg-shaped sinus, their effects on the mobile elements of
mechanical or biologic valve prosthesis are less evident and
more difficult to visualize.
For these reasons, we attempted to determine whether the
presence of vortices generated inside this initial portion of
the Dacron graft could somehow affect the hydrodynamic
performance of a mechanical or a biologic valve. In fact, the
presence of nonlaminar flow immediately above the pros-
thetic heart valve could potentially influence the opening
angle of a mechanical valve, with a direct effect on the
transvalvular gradient. A change in the opening angle might
also have a direct effect on the closure volume, because a
shorter time for valve closure leads to smaller closure
volumes.
However, the results of these experiments showed that
the differences in flow pattern immediately above the pros-
thetic heart valve did not modify or alter the normal opening
and closing behavior of the valve and thus hydrodynamic
performance. In particular, the presence of pseudosinuses of
Valsalva in the new conduit did not appear to influence the
hydrodynamic properties of prosthetic mechanical valves
(pressure drop and energy loss across the valves, as well as
the amount of back flow during and after the valve is
closed). Svensson16 recently noted that the gradient across
composite valves appears to be greater than for equivalent
“noncomposite” aortic valve sizes, suggesting the possibil-
ity that the presence of sinuses or the maintenance of a
certain root elasticity could have a positive effect on post-
operative gradients.
Similarly to the mechanical valves, the presence of vor-
tices inside the newly reconstructed root did not appear to
have any influence on the hydrodynamic behavior of bio-
logic valve prostheses. In fact, the total energy loss, which
can be considered a measure of the efficiency of the valve,
was not different between a standard conduit and one with
pseudosinuses of Valsalva. In particular, in both Dacron
grafts the total energy loss for the biologic valve was due
almost exclusively to the systolic energy losses, whereas
closure and leakage energy losses were extremely small or
absent.
The Journal of ThoracicIn conclusion, this series of experiments clearly showed
that the presence of vortices inside a single, large, egg-
shaped portion of ascending aortic graft immediately above
the aortic valve prosthesis did not modify the hydrodynamic
performances of the biologic and mechanical valves tested.
The advantages of the improved anatomic adaptability that
is peculiar to this Valsalva-type graft can therefore be
exploited without the risk of affecting prosthetic valve
performance.
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